Paras Healthcare IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Oct 21 to Oct 23 2026
Price Band
₹660 - 693
Current GMP
₹720.0 (+3.90%)
Subscription
2.34 times
IPO Details
| IPO Date | 21 to 23 Oct, 2026 |
| Listed on | Wed, Oct 28, 2026 |
| Face Value | ₹ 1 per share |
| Price Band | ₹660 to ₹693 |
| Issue Price | ₹693 per share |
| Lot Size | 21 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 2,09,23,520 shares (agg. up to ₹ 1,450 Cr) |
| Fresh Issue | 72,15,007 shares (agg. up to ₹ 500 Cr) |
| Offer for Sale | 1,37,08,513 shares of ₹ 1 (agg. up to ₹ 950 Cr) |
| Share Holding Pre Issue | 10,09,86,187 shares |
| Share Holding Post Issue | 10,82,01,194 shares |
| BSE Script Code / NSE Symbol | 545005 / PARASHLTH |
| ISIN | INE661T01029 |
IPO Date
21 to 23 Oct, 2026
Listed on
Wed, Oct 28, 2026
Face Value
₹ 1 per share
Price Band
₹660 to ₹693
Issue Price
₹693 per share
Lot Size
21 Shares
Sale Type
Fresh capital cum OFS
Issue Type
Bookbuilding IPO
Listing At
BSE, NSE
Total Issue Size
2,09,23,520 shares (agg. up to ₹ 1,450 Cr)
Fresh Issue
72,15,007 shares (agg. up to ₹ 500 Cr)
Offer for Sale
1,37,08,513 shares of ₹ 1 (agg. up to ₹ 950 Cr)
Share Holding Pre Issue
10,09,86,187 shares
Share Holding Post Issue
10,82,01,194 shares
BSE Script Code / NSE Symbol
545005 / PARASHLTH
ISIN
INE661T01029
IPO Subscription Details
| Anchor | 1 |
| QIB (Ex Anchor) | 3.25 |
| NII | 0.69 |
| bNII (> ₹10L) | 0.62 |
| sNII (< ₹10L) | 0.84 |
| Retail | 2.10 |
| Total ** | 2.34 |
Anchor
1
QIB (Ex Anchor)
3.25
NII
0.69
bNII (> ₹10L)
0.62
sNII (< ₹10L)
0.84
Retail
2.10
Total **
2.34
Day Wise Sub
| Day | QIB (Ex Anchor) | NII | NII (> ₹10L) | NII (< ₹10L) | Retail | Total |
|---|---|---|---|---|---|---|
| Oct 2 1 (Day 1) | 0.00 | 0.08 | 0.05 | 0.14 | 0.73 | 0.15 |
| Oct 2 2 (Day 2) | 0.07 | 0.26 | 0.23 | 0.33 | 1.37 | 0.36 |
| Oct 2 3 (Day 3) | 3.25 | 0.69 | 0.62 | 0.84 | 2.10 | 2.34 |
DayOct 2
1 (Day 1)
QIB (Ex Anchor)0.00
NII0.08
NII (> ₹10L)0.05
NII (< ₹10L)0.14
Retail0.73
Total0.15
DayOct 2
2 (Day 2)
QIB (Ex Anchor)0.07
NII0.26
NII (> ₹10L)0.23
NII (< ₹10L)0.33
Retail1.37
Total0.36
DayOct 2
3 (Day 3)
QIB (Ex Anchor)3.25
NII0.69
NII (> ₹10L)0.62
NII (< ₹10L)0.84
Retail2.10
Total2.34
Day Wise GMP
| GMP Date | IPO Price | GMP | Est. Listing Price |
|---|---|---|---|
| 28-10-2026 | 693 | 13 (1.88%) | 706 |
| 27-10-2026 | 693 | 13 (1.88%) | 706 |
| 26-10-2026 | 693 | 11 (1.59%) | 704 |
| 25-10-2026 | 693 | 9 (1.30%) | 702 |
| 24-10-2026 | 693 | 12 (1.73%) | 705 |
| 23-10-2026 | 693 | 11 (1.59%) | 704 |
| 22-10-2026 | 693 | 13 (1.88%) | 706 |
| 21-10-2026 | 693 | 25 (3.61%) | 718 |
| 20-10-2026 | 693 | 50 (7.22%) | 743 |
| 19-10-2026 | 693 | 78 (11.26%) | 771 |
| 18-10-2026 | 693 | 92 (13.28%) | 785 |
| 17-10-2026 | 693 | 96 (13.85%) | 789 |
| 16-10-2026 | 693 | 95 (13.71%) | 788 |
| 15-10-2026 | 693 | 95 (13.71%) | 788 |
| 14-10-2026 | 0 | 83 (0%) | 83 |
GMP Date28-10-2026
IPO Price693
GMP13 (1.88%)
Est. Listing Price706
GMP Date27-10-2026
IPO Price693
GMP13 (1.88%)
Est. Listing Price706
GMP Date26-10-2026
IPO Price693
GMP11 (1.59%)
Est. Listing Price704
GMP Date25-10-2026
IPO Price693
GMP9 (1.30%)
Est. Listing Price702
GMP Date24-10-2026
IPO Price693
GMP12 (1.73%)
Est. Listing Price705
GMP Date23-10-2026
IPO Price693
GMP11 (1.59%)
Est. Listing Price704
GMP Date22-10-2026
IPO Price693
GMP13 (1.88%)
Est. Listing Price706
GMP Date21-10-2026
IPO Price693
GMP25 (3.61%)
Est. Listing Price718
GMP Date20-10-2026
IPO Price693
GMP50 (7.22%)
Est. Listing Price743
GMP Date19-10-2026
IPO Price693
GMP78 (11.26%)
Est. Listing Price771
GMP Date18-10-2026
IPO Price693
GMP92 (13.28%)
Est. Listing Price785
GMP Date17-10-2026
IPO Price693
GMP96 (13.85%)
Est. Listing Price789
GMP Date16-10-2026
IPO Price693
GMP95 (13.71%)
Est. Listing Price788
GMP Date15-10-2026
IPO Price693
GMP95 (13.71%)
Est. Listing Price788
GMP Date14-10-2026
IPO Price0
GMP83 (0%)
Est. Listing Price83
IPO Important Dates
| IPO Open | Wed, Oct 21, 2026 |
| IPO Close | Fri, Oct 23, 2026 |
| Allotment | Mon, Oct 26, 2026 |
| Refund | Tue, Oct 27, 2026 |
| Credit of Shares | Tue, Oct 27, 2026 |
| Listing | Wed, Oct 28, 2026 |
IPO Open
Wed, Oct 21, 2026
IPO Close
Fri, Oct 23, 2026
Allotment
Mon, Oct 26, 2026
Refund
Tue, Oct 27, 2026
Credit of Shares
Tue, Oct 27, 2026
Listing
Wed, Oct 28, 2026
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 21 | ₹14,553 |
| Retail (Max) | 13 | 273 | ₹1,89,189 |
| S-HNI (Min) | 14 | 294 | ₹2,03,742 |
| S-HNI (Max) | 68 | 1428 | ₹9,89,604 |
| B-HNI (Min) | 69 | 1449 | ₹10,04,157 |
ApplicationRetail (Min)
Lots1
Shares21
Amount₹14,553
ApplicationRetail (Max)
Lots13
Shares273
Amount₹1,89,189
ApplicationS-HNI (Min)
Lots14
Shares294
Amount₹2,03,742
ApplicationS-HNI (Max)
Lots68
Shares1428
Amount₹9,89,604
ApplicationB-HNI (Min)
Lots69
Shares1449
Amount₹10,04,157
Financial Information
| Period Ended | 30 Jun 2026 | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|---|
| Assets | 2,202.88 | 2,071.14 | 1,810.45 | 1,477.66 |
| Total Income | 478.75 | 1,628.78 | 1,314.21 | 1,151.02 |
| Profit After Tax | 49.68 | 43.83 | -57.98 | -15.33 |
| EBITDA | 113.48 | 335.58 | 156.46 | 154.41 |
| NET Worth | 444.96 | 394.94 | 280.49 | 338.51 |
| Reserves and Surplus | 434.86 | 384.84 | 270.73 | 328.75 |
| Total Borrowing | 1,429.49 | 1,393.86 | 1,232.12 | 923.92 |
Period EndedAssets
30 Jun 20262,202.88
31 Mar 20262,071.14
31 Mar 20251,810.45
31 Mar 20241,477.66
Period EndedTotal Income
30 Jun 2026478.75
31 Mar 20261,628.78
31 Mar 20251,314.21
31 Mar 20241,151.02
Period EndedProfit After Tax
30 Jun 202649.68
31 Mar 202643.83
31 Mar 2025-57.98
31 Mar 2024-15.33
Period EndedEBITDA
30 Jun 2026113.48
31 Mar 2026335.58
31 Mar 2025156.46
31 Mar 2024154.41
Period EndedNET Worth
30 Jun 2026444.96
31 Mar 2026394.94
31 Mar 2025280.49
31 Mar 2024338.51
Period EndedReserves and Surplus
30 Jun 2026434.86
31 Mar 2026384.84
31 Mar 2025270.73
31 Mar 2024328.75
Period EndedTotal Borrowing
30 Jun 20261,429.49
31 Mar 20261,393.86
31 Mar 20251,232.12
31 Mar 2024923.92
Key Performance Indicator
| ROE | 11.83% |
| ROCE | 4.23% |
| Debt/Equity | 3.21 |
| RoNW | 11.83% |
| PAT Margin | 10.38% |
| EBITDA Margin | 23.70% |
| NAV | 44.06 |
| P/B (x) | 15.73 |
ROE
11.83%
ROCE
4.23%
Debt/Equity
3.21
RoNW
11.83%
PAT Margin
10.38%
EBITDA Margin
23.70%
NAV
44.06
P/B (x)
15.73
Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (₹ per share) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Paras Healthcare Ltd. | 4.34 | 4.34 | 39.11 | 12.98 | Consolidated | ||
| Aster DM Quality Care Ltd. | 7.53 | 7.52 | 88.32 | 91.89 | 9.70 | 7.85 | Consolidated |
| Apollo Hospitals Enterprise Ltd. | 135.04 | 134.94 | 657.58 | 59.36 | 21.95 | 12.19 | Consolidated |
| Fortis Healthcare Ltd. | 13.80 | 13.80 | 131.07 | 55.43 | 11.08 | 5.84 | Consolidated |
| Global Health Ltd. | 20.71 | 20.66 | 147.06 | 64.46 | 15.15 | 9.05 | Consolidated |
| Jupiter Lifeline Hospitals Ltd. | 5.92 | 5.92 | 47.10 | 42.92 | 13.41 | 5.40 | Consolidated |
| Krishna Institute of Medical Sciences Ltd. | 6.03 | 6.03 | 56.17 | 116.41 | 11.01 | 12.52 | Consolidated |
| Manipal Health Enterprises Ltd. | 7.71 | 7.67 | 63.26 | 87.00 | 12.37 | 10.59 | Consolidated |
| Max Healthcare Institute Ltd. | 14.83 | 14.76 | 109.53 | 62.10 | 14.33 | 8.40 | Consolidated |
| Narayana Hrudayalaya Ltd. | 39.67 | 39.67 | 222.02 | 43.41 | 19.74 | 7.75 | Consolidated |
| Yatharth Hospital and Trauma Care Services Ltd. | 18.20 | 18.20 | 184.79 | 55.16 | 10.36 | 5.45 | Consolidated |
Company NameParas Healthcare Ltd.
EPS (Basic)4.34
EPS (Diluted)4.34
NAV (₹ per share)39.11
P/E (x)
RoNW (%)12.98
P/BV Ratio
Financial statementsConsolidated
Company NameAster DM Quality Care Ltd.
EPS (Basic)7.53
EPS (Diluted)7.52
NAV (₹ per share)88.32
P/E (x)91.89
RoNW (%)9.70
P/BV Ratio7.85
Financial statementsConsolidated
Company NameApollo Hospitals Enterprise Ltd.
EPS (Basic)135.04
EPS (Diluted)134.94
NAV (₹ per share)657.58
P/E (x)59.36
RoNW (%)21.95
P/BV Ratio12.19
Financial statementsConsolidated
Company NameFortis Healthcare Ltd.
EPS (Basic)13.80
EPS (Diluted)13.80
NAV (₹ per share)131.07
P/E (x)55.43
RoNW (%)11.08
P/BV Ratio5.84
Financial statementsConsolidated
Company NameGlobal Health Ltd.
EPS (Basic)20.71
EPS (Diluted)20.66
NAV (₹ per share)147.06
P/E (x)64.46
RoNW (%)15.15
P/BV Ratio9.05
Financial statementsConsolidated
Company NameJupiter Lifeline Hospitals Ltd.
EPS (Basic)5.92
EPS (Diluted)5.92
NAV (₹ per share)47.10
P/E (x)42.92
RoNW (%)13.41
P/BV Ratio5.40
Financial statementsConsolidated
Company NameKrishna Institute of Medical Sciences Ltd.
EPS (Basic)6.03
EPS (Diluted)6.03
NAV (₹ per share)56.17
P/E (x)116.41
RoNW (%)11.01
P/BV Ratio12.52
Financial statementsConsolidated
Company NameManipal Health Enterprises Ltd.
EPS (Basic)7.71
EPS (Diluted)7.67
NAV (₹ per share)63.26
P/E (x)87.00
RoNW (%)12.37
P/BV Ratio10.59
Financial statementsConsolidated
Company NameMax Healthcare Institute Ltd.
EPS (Basic)14.83
EPS (Diluted)14.76
NAV (₹ per share)109.53
P/E (x)62.10
RoNW (%)14.33
P/BV Ratio8.40
Financial statementsConsolidated
Company NameNarayana Hrudayalaya Ltd.
EPS (Basic)39.67
EPS (Diluted)39.67
NAV (₹ per share)222.02
P/E (x)43.41
RoNW (%)19.74
P/BV Ratio7.75
Financial statementsConsolidated
Company NameYatharth Hospital and Trauma Care Services Ltd.
EPS (Basic)18.20
EPS (Diluted)18.20
NAV (₹ per share)184.79
P/E (x)55.16
RoNW (%)10.36
P/BV Ratio5.45
Financial statementsConsolidated
IPO Reservation
| QIB | 1,56,92,640 |
| − Anchor Investor | 94,15,584 |
| − QIB (Ex. Anchor) | 62,77,056 |
| NII (HNI) | 31,38,528 |
| − bNII > ₹10L | 20,92,352 |
| − sNII < ₹10L | 10,46,176 |
| Retail | 20,92,352 |
| Total | 2,09,23,520 |
QIB
1,56,92,640
− Anchor Investor
94,15,584
− QIB (Ex. Anchor)
62,77,056
NII (HNI)
31,38,528
− bNII > ₹10L
20,92,352
− sNII < ₹10L
10,46,176
Retail
20,92,352
Total
2,09,23,520
Information about company
Incorporated in1987, Paras Healthcare Limited is a leading clinical specialty-led hospital platform providing tertiary and quaternary healthcare services across North India, Bihar, and Jharkhand under the "Paras Health" brand. The company operates eight hospitals with an aggregate bed capacity of 2,211 beds across Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi, and Srinagar as of June 30, 2026.
It specializes in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics & sports injury, and renal sciences (CONGOR specialties), which contributed 75.30% of revenue in Fiscal 2026.
Paras Healthcare has over 20 years of operating history and follows a balanced growth strategy through mature, emerging, and new hospitals. The company plans to expand its network with a 300-bed hospital in Gurugram and a 500-bed hospital in Ludhiana, increasing total capacity to 3,011 beds by March 2028.
As of March 31, 2026, it had 4,670 employees, including 1,084 doctors and 1,937 nurses.
Strengths
Objectives of IPO
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
#: Issue Objects
1: Prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by Company
2: Investment in our wholly owned Subsidiary, PMHPL (which also operates hospital in Srinagar), for repayment/prepayment of borrowings, in full or part, of PMHPL
3: General Corporate Purposes
4: Issue Expenses
: Total
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App